Burjeel Holdings reported strong financial results for the first quarter of 2026, driven by sustained demand for specialised healthcare services and continued expansion across the UAE and Saudi Arabia.
The group, listed on the Abu Dhabi Securities Exchange (ADX: BURJEEL), said revenue increased 5.1 percent year-on-year to AED 1.339 billion, supported by a 7.2 percent rise in patient footfall despite the earlier onset of Ramadan, adverse weather conditions, and regional developments in March.
Excluding the impact of the Unified Procurement Program (UPP), normalised revenue growth reached 9.7 percent year-on-year. Total patient visits reached around 1.8 million, with outpatient volumes increasing 7.3 percent and inpatient volumes rising 5.9 percent.
The company continued executing its expansion strategy with the opening of a new medical centre in Dubai Silicon Oasis and the expansion of outpatient and aesthetics services under the Tajmeel brand. It also launched specialised centres in oncology, cardiology, and rare diseases.
EBITDA rose 11.2 percent year-on-year to AED 201 million, with margins improving to 15.0 percent compared to 14.2 percent in the same period last year. Net profit increased 44.5 percent to AED 57 million.
Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, said the quarter unfolded against a challenging regional backdrop and acknowledged the UAE leadership’s role in ensuring stability and continuity across key sectors.
He added that the organisation maintained uninterrupted, high-quality care throughout the period, reflecting the resilience of its network and operating model.
Dr. Vayalil also highlighted ongoing investments in expansion, advanced medical capabilities, digital transformation, and international partnerships to support long-term growth and strengthen Burjeel Holdings’ position as a leading specialised healthcare provider in the region.
